Ortega-Joaquín N, Echave M, Provencio M, Garrido C, González P
Efficiency of nivolumab in the treatment of second-line advanced non-squamous non-small cell lung cancer (NSCLC) in Spain
Annual Congress of the European Society for Medical Oncology (ESMO). Madrid. 8-12 sep 2017
Seguí MA, Durán I, Isla D, Oyagüez I, Roldán C, Casado MA, Lothgren M, Hechmati G, Danese M, Gutiérrez L, Gasquet JA
Cost-effectiveness of denosumab versus zoledronic acid in patients with bone metastases from solid tumours in Spain
European Cancer Congress 2013 (ECCO-ESMO-ESTRO). Amsterdam, Holanda. 27 sep-1 oct 2013
Vieitez JM, Oyagüez I, Casado MA
Cost of analysis of metastatic colorectal cancer treatment with bevacizumab and cetuximab
13th World Congress on Gastrointestinal Cancer (ESMO). Barcelona, España. 22-25 jun 2011
Puente J, Calderero V, García-Muro X, Trigo JM, Castro AJ, Martín-Escudero V, Yébenes M, Casado MA